Related references
Note: Only part of the references are listed.Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
Madeleine Duvic et al.
BLOOD (2015)
Genomic landscape of cutaneous T cell lymphoma
Jaehyuk Choi et al.
NATURE GENETICS (2015)
Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2
Alexander Ungewickell et al.
NATURE GENETICS (2015)
Resident memory T cells in human health and disease
Rachael A. Clark
SCIENCE TRANSLATIONAL MEDICINE (2015)
Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome
Xiao Ni et al.
CLINICAL CANCER RESEARCH (2015)
CCR4 and its ligands: from bench to bedside
Osamu Yoshie et al.
INTERNATIONAL IMMUNOLOGY (2015)
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sezary syndrome: where are we now?
J. J. Scarisbrick et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma
Masao Nakagawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
The Role of IL-32 in Cutaneous T-Cell Lymphoma
Hiraku Suga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Novel somatic and germline mutations in intracranial germ cell tumours
Linghua Wang et al.
NATURE (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Robert Huether et al.
NATURE COMMUNICATIONS (2014)
IL32 Is Progressively Expressed in Mycosis Fungoides Independent of Helper T-cell 2 and Helper T-cell 9 Polarization
Hanako Ohmatsu et al.
CANCER IMMUNOLOGY RESEARCH (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
From human genome to cancer genome: The first decade
David A. Wheeler et al.
GENOME RESEARCH (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al.
NATURE IMMUNOLOGY (2013)
RNA-SeQC: RNA-seq metrics for quality control and process optimization
David S. DeLuca et al.
BIOINFORMATICS (2012)
The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome
B. Lamprecht et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sezary Syndrome from 1982 to 2009
Rakhshandra Talpur et al.
CLINICAL CANCER RESEARCH (2012)
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of novel transcripts in annotated genomes using RNA-Seq
Adam Roberts et al.
BIOINFORMATICS (2011)
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome
F. C. M. Braun et al.
LEUKEMIA (2011)
deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
Andrew McPherson et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors
James J. Campbell et al.
BLOOD (2010)
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Nita Sally Agar et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Downregulation of Fas Gene Expression in Sezary Syndrome Is Associated with Promoter Hypermethylation
Christine L. Jones et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma
Elodie Laharanne et al.
MODERN PATHOLOGY (2010)
Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-β1-mediated growth suppression in adult T-cell leukemia/lymphoma
S. Nakahata et al.
ONCOGENE (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Porcia T. Bradford et al.
BLOOD (2009)
Identification of Key Regions and Genes Important in the Pathogenesis of Sezary Syndrome by Combining Genomic and Expression Microarrays
Elisabetta Caprini et al.
CANCER RESEARCH (2009)
Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma
Kelley A. Vidulich et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Cutaneous T-Cell Lymphoma: Roles for Chemokines and Chemokine Receptors
Xue-Song Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma
Tomonori Hidaka et al.
BLOOD (2008)
Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sezary syndrome
R. Talpur et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Novel and highly recurrent chromosomal alterations in Sezary syndrome
Maarten H. Vermeer et al.
CANCER RESEARCH (2008)
The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations
Hyun-Ja Nam et al.
CELLULAR SIGNALLING (2008)
Interleukin-32 monoclonal antibodies for Immunohistochemistry, Western blotting, and ELISA
Ki-Hong Kim et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
Novel Therapies for Cutaneous T-Cell Lymphomas
Steven M. Horwitz
CLINICAL LYMPHOMA & MYELOMA (2008)
E2F-associated chromatin modifiers and cell cycle control
Alexandre Blais et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Mycosis fungoides: Pathophysiology and emerging therapies
Madeleine Duvic et al.
SEMINARS IN ONCOLOGY (2007)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control
Norman G. Nagl et al.
EMBO JOURNAL (2007)
Multicolor fluorescence in situ hybridization (SKY) in mycosis fungoides and Sezary syndrome: Search for recurrent chromosome abnormalities
DAS Batista et al.
GENES CHROMOSOMES & CANCER (2006)
Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation
R Matsumoto et al.
IMMUNITY (2005)
Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas
X Ni et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Medical progress - The pathogenesis of mycosis fungoides
M Girardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The MAGUK family protein CARD11 is essential for lymphocyte activation
H Hara et al.
IMMUNITY (2003)
Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sezary syndrome
KL Herne et al.
BLOOD (2003)
Molecular cytogenetic characterization of Sezary syndrome
X Mao et al.
GENES CHROMOSOMES & CANCER (2003)
Clonal heterogeneity in mycosis fungoides and its relationship to clinical course
F Vega et al.
BLOOD (2002)
A requirement for CARMA1 in TCR-induced NF-κB activation
DH Wang et al.
NATURE IMMUNOLOGY (2002)
Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+T lymphocytes in cutaneous T-cell lymphomas
O Dereure et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
